Global 23-valent Pneumococcal Vaccine Market Research Report 2021

Global 23-valent Pneumococcal Vaccine Market Research Report 2021

Table of Contents
1 23-valent Pneumococcal Vaccine Market Overview
1.1 Product Overview and Scope of 23-valent Pneumococcal Vaccine
1.2 23-valent Pneumococcal Vaccine Segment by Type
1.2.1 Global 23-valent Pneumococcal Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 23-valent Pneumococcal Vaccine Segment by Application
1.3.1 Global 23-valent Pneumococcal Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Chronic Cardiovascular Disease
1.3.3 Chronic Lung Disease
1.3.4 Chronic Liver Disease
1.3.5 People Living with Hiv
1.3.6 Leukemia
1.3.7 Lymphoma
1.3.8 Multiple Myeloma
1.3.9 General Malignancy
1.3.10 Chronic Kidney Disease
1.3.11 Other
1.4 Global 23-valent Pneumococcal Vaccine Market Size Estimates and Forecasts
1.4.1 Global 23-valent Pneumococcal Vaccine Revenue 2016-2027
1.4.2 Global 23-valent Pneumococcal Vaccine Sales 2016-2027
1.4.3 23-valent Pneumococcal Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027
2 23-valent Pneumococcal Vaccine Market Competition by Manufacturers
2.1 Global 23-valent Pneumococcal Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global 23-valent Pneumococcal Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global 23-valent Pneumococcal Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers 23-valent Pneumococcal Vaccine Manufacturing Sites, Area Served, Product Type
2.5 23-valent Pneumococcal Vaccine Market Competitive Situation and Trends
2.5.1 23-valent Pneumococcal Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest 23-valent Pneumococcal Vaccine Players Market Share by Revenue
2.5.3 Global 23-valent Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 23-valent Pneumococcal Vaccine Retrospective Market Scenario by Region
3.1 Global 23-valent Pneumococcal Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global 23-valent Pneumococcal Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America 23-valent Pneumococcal Vaccine Market Facts & Figures by Country
3.3.1 North America 23-valent Pneumococcal Vaccine Sales by Country
3.3.2 North America 23-valent Pneumococcal Vaccine Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe 23-valent Pneumococcal Vaccine Market Facts & Figures by Country
3.4.1 Europe 23-valent Pneumococcal Vaccine Sales by Country
3.4.2 Europe 23-valent Pneumococcal Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific 23-valent Pneumococcal Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific 23-valent Pneumococcal Vaccine Sales by Region
3.5.2 Asia Pacific 23-valent Pneumococcal Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America 23-valent Pneumococcal Vaccine Market Facts & Figures by Country
3.6.1 Latin America 23-valent Pneumococcal Vaccine Sales by Country
3.6.2 Latin America 23-valent Pneumococcal Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa 23-valent Pneumococcal Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa 23-valent Pneumococcal Vaccine Sales by Country
3.7.2 Middle East and Africa 23-valent Pneumococcal Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global 23-valent Pneumococcal Vaccine Historic Market Analysis by Type
4.1 Global 23-valent Pneumococcal Vaccine Sales Market Share by Type (2016-2021)
4.2 Global 23-valent Pneumococcal Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global 23-valent Pneumococcal Vaccine Price by Type (2016-2021)
5 Global 23-valent Pneumococcal Vaccine Historic Market Analysis by Application
5.1 Global 23-valent Pneumococcal Vaccine Sales Market Share by Application (2016-2021)
5.2 Global 23-valent Pneumococcal Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global 23-valent Pneumococcal Vaccine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck 23-valent Pneumococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merck 23-valent Pneumococcal Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Sanofipasteur
6.2.1 Sanofipasteur Corporation Information
6.2.2 Sanofipasteur Description and Business Overview
6.2.3 Sanofipasteur 23-valent Pneumococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sanofipasteur 23-valent Pneumococcal Vaccine Product Portfolio
6.2.5 Sanofipasteur Recent Developments/Updates
6.3 CDIBP
6.3.1 CDIBP Corporation Information
6.3.2 CDIBP Description and Business Overview
6.3.3 CDIBP 23-valent Pneumococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 CDIBP 23-valent Pneumococcal Vaccine Product Portfolio
6.3.5 CDIBP Recent Developments/Updates
6.4 Kexing Bio
6.4.1 Kexing Bio Corporation Information
6.4.2 Kexing Bio Description and Business Overview
6.4.3 Kexing Bio 23-valent Pneumococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Kexing Bio 23-valent Pneumococcal Vaccine Product Portfolio
6.4.5 Kexing Bio Recent Developments/Updates
6.5 Changsheng Bio-Technology
6.5.1 Changsheng Bio-Technology Corporation Information
6.5.2 Changsheng Bio-Technology Description and Business Overview
6.5.3 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product Portfolio
6.5.5 Changsheng Bio-Technology Recent Developments/Updates
6.6 Huaan Science and Technology Innovation
6.6.1 Huaan Science and Technology Innovation Corporation Information
6.6.2 Huaan Science and Technology Innovation Description and Business Overview
6.6.3 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product Portfolio
6.6.5 Huaan Science and Technology Innovation Recent Developments/Updates
7 23-valent Pneumococcal Vaccine Manufacturing Cost Analysis
7.1 23-valent Pneumococcal Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of 23-valent Pneumococcal Vaccine
7.4 23-valent Pneumococcal Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 23-valent Pneumococcal Vaccine Distributors List
8.3 23-valent Pneumococcal Vaccine Customers
9 23-valent Pneumococcal Vaccine Market Dynamics
9.1 23-valent Pneumococcal Vaccine Industry Trends
9.2 23-valent Pneumococcal Vaccine Growth Drivers
9.3 23-valent Pneumococcal Vaccine Market Challenges
9.4 23-valent Pneumococcal Vaccine Market Restraints
10 Global Market Forecast
10.1 23-valent Pneumococcal Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of 23-valent Pneumococcal Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of 23-valent Pneumococcal Vaccine by Type (2022-2027)
10.2 23-valent Pneumococcal Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of 23-valent Pneumococcal Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of 23-valent Pneumococcal Vaccine by Application (2022-2027)
10.3 23-valent Pneumococcal Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of 23-valent Pneumococcal Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of 23-valent Pneumococcal Vaccine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global 23-valent Pneumococcal Vaccine Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global 23-valent Pneumococcal Vaccine Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global 23-valent Pneumococcal Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers 23-valent Pneumococcal Vaccine Covered in This Study
Table 5. Global 23-valent Pneumococcal Vaccine Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global 23-valent Pneumococcal Vaccine Sales Market Share by Manufacturers (2016-2021)
Table 7. Global 23-valent Pneumococcal Vaccine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global 23-valent Pneumococcal Vaccine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market 23-valent Pneumococcal Vaccine Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers 23-valent Pneumococcal Vaccine Manufacturing Sites and Area Served
Table 11. Manufacturers 23-valent Pneumococcal Vaccine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global 23-valent Pneumococcal Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 23-valent Pneumococcal Vaccine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global 23-valent Pneumococcal Vaccine Sales by Region (2016-2021) & (K Units)
Table 16. Global 23-valent Pneumococcal Vaccine Sales Market Share by Region (2016-2021)
Table 17. Global 23-valent Pneumococcal Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America 23-valent Pneumococcal Vaccine Sales by Country (2016-2021) & (K Units)
Table 19. North America 23-valent Pneumococcal Vaccine Sales Market Share by Country (2016-2021)
Table 20. North America 23-valent Pneumococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2016-2021)
Table 22. Europe 23-valent Pneumococcal Vaccine Sales by Country (2016-2021) & (K Units)
Table 23. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Country (2016-2021)
Table 24. Europe 23-valent Pneumococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific 23-valent Pneumococcal Vaccine Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific 23-valent Pneumococcal Vaccine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific 23-valent Pneumococcal Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific 23-valent Pneumococcal Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Latin America 23-valent Pneumococcal Vaccine Sales by Country (2016-2021) & (K Units)
Table 31. Latin America 23-valent Pneumococcal Vaccine Sales Market Share by Country (2016-2021)
Table 32. Latin America 23-valent Pneumococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa 23-valent Pneumococcal Vaccine Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa 23-valent Pneumococcal Vaccine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa 23-valent Pneumococcal Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2016-2021)
Table 38. Global 23-valent Pneumococcal Vaccine Sales (K Units) by Type (2016-2021)
Table 39. Global 23-valent Pneumococcal Vaccine Sales Market Share by Type (2016-2021)
Table 40. Global 23-valent Pneumococcal Vaccine Revenue (Million US$) by Type (2016-2021)
Table 41. Global 23-valent Pneumococcal Vaccine Revenue Share by Type (2016-2021)
Table 42. Global 23-valent Pneumococcal Vaccine Price (US$/Unit) by Type (2016-2021)
Table 43. Global 23-valent Pneumococcal Vaccine Sales (K Units) by Application (2016-2021)
Table 44. Global 23-valent Pneumococcal Vaccine Sales Market Share by Application (2016-2021)
Table 45. Global 23-valent Pneumococcal Vaccine Revenue (Million US$) by Application (2016-2021)
Table 46. Global 23-valent Pneumococcal Vaccine Revenue Share by Application (2016-2021)
Table 47. Global 23-valent Pneumococcal Vaccine Price (US$/Unit) by Application (2016-2021)
Table 48. Merck Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck 23-valent Pneumococcal Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Merck 23-valent Pneumococcal Vaccine Product
Table 52. Merck Recent Developments/Updates
Table 53. Sanofipasteur Corporation Information
Table 54. Sanofipasteur Description and Business Overview
Table 55. Sanofipasteur 23-valent Pneumococcal Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Sanofipasteur 23-valent Pneumococcal Vaccine Product
Table 57. Sanofipasteur Recent Developments/Updates
Table 58. CDIBP Corporation Information
Table 59. CDIBP Description and Business Overview
Table 60. CDIBP 23-valent Pneumococcal Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. CDIBP 23-valent Pneumococcal Vaccine Product
Table 62. CDIBP Recent Developments/Updates
Table 63. Kexing Bio Corporation Information
Table 64. Kexing Bio Description and Business Overview
Table 65. Kexing Bio 23-valent Pneumococcal Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Kexing Bio 23-valent Pneumococcal Vaccine Product
Table 67. Kexing Bio Recent Developments/Updates
Table 68. Changsheng Bio-Technology Corporation Information
Table 69. Changsheng Bio-Technology Description and Business Overview
Table 70. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product
Table 72. Changsheng Bio-Technology Recent Developments/Updates
Table 73. Huaan Science and Technology Innovation Corporation Information
Table 74. Huaan Science and Technology Innovation Description and Business Overview
Table 75. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product
Table 77. Huaan Science and Technology Innovation Recent Developments/Updates
Table 78. Production Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. 23-valent Pneumococcal Vaccine Distributors List
Table 81. 23-valent Pneumococcal Vaccine Customers List
Table 82. 23-valent Pneumococcal Vaccine Market Trends
Table 83. 23-valent Pneumococcal Vaccine Growth Drivers
Table 84. 23-valent Pneumococcal Vaccine Market Challenges
Table 85. 23-valent Pneumococcal Vaccine Market Restraints
Table 86. Global 23-valent Pneumococcal Vaccine Sales Forecast by Type (2022-2027) & (K Units)
Table 87. Global 23-valent Pneumococcal Vaccine Sales Market Share Forecast by Type (2022-2027)
Table 88. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 89. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Type (2022-2027)
Table 90. Global 23-valent Pneumococcal Vaccine Sales Forecast by Application (2022-2027) & (K Units)
Table 91. Global 23-valent Pneumococcal Vaccine Sales Market Share Forecast by Application (2022-2027)
Table 92. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 93. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Application (2022-2027)
Table 94. Global 23-valent Pneumococcal Vaccine Sales Forecast by Region (2022-2027) & (K Units)
Table 95. Global 23-valent Pneumococcal Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 96. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 97. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Region (2022-2027)
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of 23-valent Pneumococcal Vaccine
Figure 2. Global 23-valent Pneumococcal Vaccine Market Share by Type in 2020 & 2027
Figure 3. Single Dose Vial Product Picture
Figure 4. Pre-filled Syringe Product Picture
Figure 5. Global 23-valent Pneumococcal Vaccine Market Share by Application in 2020 & 2027
Figure 6. Chronic Cardiovascular Disease
Figure 7. Chronic Lung Disease
Figure 8. Chronic Liver Disease
Figure 9. People Living with Hiv
Figure 10. Leukemia
Figure 11. Lymphoma
Figure 12. Multiple Myeloma
Figure 13. General Malignancy
Figure 14. Chronic Kidney Disease
Figure 15. Other
Figure 16. Global 23-valent Pneumococcal Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global 23-valent Pneumococcal Vaccine Market Size 2016-2027 (US$ Million)
Figure 18. Global 23-valent Pneumococcal Vaccine Sales 2016-2027 (K Units)
Figure 19. Global 23-valent Pneumococcal Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 20. 23-valent Pneumococcal Vaccine Sales Share by Manufacturers in 2020
Figure 21. Global 23-valent Pneumococcal Vaccine Revenue Share by Manufacturers in 2020
Figure 22. The Global 5 and 10 Largest 23-valent Pneumococcal Vaccine Players: Market Share by Revenue in 2020
Figure 23. 23-valent Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 24. Global 23-valent Pneumococcal Vaccine Sales Market Share by Region (2016-2021)
Figure 25. Global 23-valent Pneumococcal Vaccine Sales Market Share by Region in 2020
Figure 26. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Region (2016-2021)
Figure 27. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Region in 2020
Figure 28. United States 23-valent Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Canada 23-valent Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Germany 23-valent Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. France 23-valent Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. U.K. 23-valent Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Italy 23-valent Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Russia 23-valent Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. China 23-valent Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Japan 23-valent Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. South Korea 23-valent Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. India 23-valent Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Australia 23-valent Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Taiwan 23-valent Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Indonesia 23-valent Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Thailand 23-valent Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Malaysia 23-valent Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Mexico 23-valent Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Brazil 23-valent Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Argentina 23-valent Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Colombia 23-valent Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Turkey 23-valent Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Saudi Arabia 23-valent Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. UAE 23-valent Pneumococcal Vaccine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Sales Market Share of 23-valent Pneumococcal Vaccine by Type (2016-2021)
Figure 52. Sales Market Share of 23-valent Pneumococcal Vaccine by Application (2016-2021)
Figure 53. Sales Market Share of 23-valent Pneumococcal Vaccine by Application in 2020
Figure 54. Revenue Share of 23-valent Pneumococcal Vaccine by Application (2016-2021)
Figure 55. Revenue Share of 23-valent Pneumococcal Vaccine by Application in 2020
Figure 56. Manufacturing Cost Structure of 23-valent Pneumococcal Vaccine
Figure 57. Manufacturing Process Analysis of 23-valent Pneumococcal Vaccine
Figure 58. 23-valent Pneumococcal Vaccine Industrial Chain Analysis
Figure 59. Channels of Distribution
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs